Jacob and Nikhil sit down with Dotmatics CEO Thomas Swalla to discuss R&D software, differences in software requirements across biotechs, growing through 11 acquisitions and expanding beyond life sciences.
0:00 intro
0:36 getting into healthcare
5:20 what R&D looks like today
8:03 what does Dotmatics do?
13:06 differences in software requirements across biotechs
20:15 bundling vs. “best-of-breed”
23:46 do life sciences need their own data tools?
26:44 incorporating AI into Dotmatics tools
34:38 AI replacing scientists
37:39 how Dotmatics tools can serve companies outside of life sciences
39:50 acquisition strategy
44:43 spaces for innovation in R&D
